Article
Angiopoietin-2 and vascular endothelial growth factor α inhibition by faricimab reduces pericyte-to-myofibroblast transition and the myofibroblast phenotype in vitro.
Experimental eye research - 1 Jun 2026
Koller Andreas, Preishuber-Pflügl Julia, Migschitz Susanne Maria, Pichler Nicola Aponi, Runge Christian, Lenzhofer Markus, Reitsamer Herbert Anton, Trost Andrea
Abstract excerpt
Pericytes (PCs) are essential components of the retinal microvasculature and exhibit fibrotic activity, which is crucial for tissue repair and regeneration. However, chronic fibrotic activity can lead to harmful fibrosis that impairs retinal function. Treatment with faricimab, which targets angiopoietin-2 and vascular endothelial growth factor α (VEGFα) to prevent neovascularization in diabetic macular edema...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
